###begin article-title 0
The role of senescence and prosurvival signaling in controlling the oncogenic activity of FGFR2 mutants associated with cancer and birth defects
###end article-title 0
###begin p 1
###xml 62 67 <span type="species:ncbi:9606">human</span>
###xml 444 449 <span type="species:ncbi:10090">mouse</span>
###xml 454 459 <span type="species:ncbi:9606">human</span>
Mutations in fibroblast growth factor receptors (FGFRs) cause human birth defect syndromes and are associated with a variety of cancers. Although forced expression of mutant activated FGFRs has been shown to oncogenically transform some immortal cell types, their activity in primary cells remains unclear. Here, we show that birth defect and cancer-associated FGFR2 mutants promote DNA-damage signaling and p53-dependent senescence in primary mouse and human cells. Senescence promoted by FGFR mutants was associated with downregulation of c-Myc and forced expression of c-Myc facilitated senescence escape. Whereas c-Myc expression facilitated senescence bypass, mutant FGFR2 signaling suppressed c-Myc-dependent apoptosis and led to oncogenic transformation. Cells transformed by coexpression of a constitutively activated FGFR2 mutant plus c-Myc appeared to be become highly addicted to FGFR-dependent prosurvival activities, as small molecule inhibition of FGFR signaling resulted in robust p53-dependent apoptosis. Our data suggest that senescence-promoting activities of mutant FGFRs may normally limit their oncogenic potential and may be relevant to their ability to disrupt morphogenesis and cause birth defects. Our results also raise the possibility that cancers originating through a combination of constitutive FGFR activation and deregulated Myc expression may be particularly sensitive to small molecule inhibitors of FGF receptors.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 723 724 719 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C1">1</xref>
###xml 1041 1042 1037 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C2">2</xref>
###xml 1043 1044 1039 1040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C3">3</xref>
Fibroblast growth factor signaling plays crucial roles during embryonic development by regulating cell proliferation, differentiation, survival, cell-cell communication and cell fate specification. The biological effects of FGF ligands are mediated by binding to FGF receptors, which induce receptor dimerization, autophosphorylation and the assembly of signaling complexes. Fibroblast growth factor receptor (FGFR) activation initiates several different phosphorylation cascades whose combined actions dictate their effects on cell behavior. Signaling pathways controlled by FGFs include the phospholipase C-gamma (PLC-gamma), phosphatidylinositol-3 kinase (PI3K) and Ras/mitogen-activated protein kinase (MAPK) pathways (1). The strength, anatomical location and duration of FGF signaling are of critical importance during embryonic development and mutations in FGFRs that either cause constitutive FGFR activation, altered receptor dimerization or influence ligand-binding specificity or affinity, can lead to a variety of birth defects (2,3).
###end p 3
###begin p 4
###xml 90 95 90 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGFRs</italic>
###xml 187 192 187 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGFR2</italic>
###xml 238 239 238 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C4">4</xref>
###xml 240 241 240 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C7">7</xref>
###xml 257 262 257 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGFR3</italic>
###xml 299 300 299 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C8">8</xref>
###xml 324 325 324 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C9">9</xref>
###xml 326 328 326 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C10">10</xref>
###xml 348 353 348 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGFR1</italic>
###xml 387 389 387 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C11">11</xref>
###xml 405 410 405 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGFR3</italic>
###xml 477 479 477 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C12">12</xref>
###xml 480 482 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C14">14</xref>
###xml 527 532 527 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGFR2</italic>
###xml 561 566 561 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGFR2</italic>
###xml 634 636 634 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C15">15</xref>
###xml 637 639 637 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C17">17</xref>
###xml 657 661 657 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGFR</italic>
###xml 673 677 673 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGFR</italic>
###xml 714 719 714 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGFR2</italic>
###xml 721 723 721 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C18">18</xref>
In addition to causing developmental defects, activating or gain-of-function mutations in FGFRs are found sporadically in a number of different types of cancer. For example, mutations in FGFR2 are found in endometrial and gastric tumors (4-7), mutations in FGFR3 are found in urothelial carcinomas (8) and multiple myeloma (9,10), and mutations in FGFR1 have been found in glioblastoma (11). Mutations in FGFR3 are also found in benign epidermal nevi and seborrheic keratoses (12-14) and single nucleotide polymorphisms in the FGFR2 gene that lead to increased FGFR2 transcription are associated with increased risk of breast cancer (15-17). In addition to FGFR mutations, FGFR gene amplification, particularly of FGFR2 (18), is associated with several different cancers.
###end p 4
###begin p 5
###xml 123 128 123 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGFR3</italic>
###xml 133 138 133 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGFR2</italic>
###xml 216 217 216 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C7">7</xref>
###xml 218 220 218 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C19">19</xref>
###xml 221 223 221 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C22">22</xref>
###xml 413 414 413 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C1">1</xref>
###xml 415 417 415 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C23">23</xref>
###xml 734 735 734 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C1">1</xref>
###xml 198 203 <span type="species:ncbi:10090">mouse</span>
Consistent with direct participation in tumorigenesis, a number of studies have shown that expression of cancer-associated FGFR3 and FGFR2 mutations can promote oncogenic transformation of immortal mouse cell lines (7,19-22). However, their effects in both immortal and primary cells appear to be highly cell type specific and proliferation of some cell types is strongly inhibited by FGFR signaling (reviewed in 1,23). Although the mechanisms responsible for the different responses that cells have to mutant FGFRs remain unclear, it has been postulated to be related to their ability to engage signaling pathways that can both promote proliferation and suppress proliferation, as well as by triggering negative feedback mechanisms (1).
###end p 5
###begin p 6
###xml 350 352 350 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C24">24</xref>
###xml 477 479 477 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C25">25</xref>
###xml 480 482 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C27">27</xref>
###xml 568 569 568 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C4">4</xref>
###xml 570 571 570 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C7">7</xref>
###xml 721 724 721 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAS</italic>
###xml 768 776 768 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAS/MAPK</italic>
###xml 889 891 889 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C28">28</xref>
###xml 892 894 892 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C30">30</xref>
###xml 1027 1029 1027 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C31">31</xref>
###xml 1304 1306 1304 1306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C32">32</xref>
###xml 1307 1309 1307 1309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C33">33</xref>
###xml 1662 1664 1662 1664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C34">34</xref>
###xml 1665 1667 1665 1667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C36">36</xref>
###xml 319 324 <span type="species:ncbi:10090">mouse</span>
Although FGF receptors can activate different signal transduction pathways, the Ras/Raf/MAPK pathway appears to be of critical importance in mediating the effects of activated FGF receptors. For example, it was recently shown that small molecule-mediated suppression of Ras/MAPK signaling rescued craniosynostosis in a mouse model of Apert syndrome (24), a disease caused by mutations in FGFR2 that result in broadened ligand-binding specificity and increased ligand affinity (25-27). Since the same mutations that cause Apert syndrome are also found in some cancers (4-7), it seems likely that increased Ras/MAPK signaling plays an important role in their oncogenic activities. However, although activating mutations in RAS family members and other components of the RAS/MAPK pathway are frequent events in cancer, their expression in at least some primary cell types induces senescence (28-30). Similarly, the PI3K pathway, a major pathway activated by FGFRs, has been demonstrated to promote senescence when hyperactivated (31). While senescence appears to be triggered by multiple mechanisms, recent evidence indicates that senescence induced by mutant Ras and several other oncogenic proteins is associated with the development of DNA strand breaks that may arise due to defects in DNA replication (32,33). The induction of senescence and/or apoptosis by oncogenic proteins is associated with chronic activation of DNA-damage signaling that normally functions to arrest cell proliferation and promote repair. This cellular response to oncogenic proteins appears to provide a significant barrier to further progression towards a malignant state (reviewed in 34-36).
###end p 6
###begin p 7
###xml 156 161 <span type="species:ncbi:9606">human</span>
Here we investigated the potential role that senescence might play in regulating the oncogenic activities of mutant forms of FGFR2 that are associated with human birth defects and cancer. We show that gain-of-function and constitutively active FGFR2 mutants promote DNA-damage signaling and p53-dependent senescence. Induction of senescence was linked to downregulation of c-Myc and forced expression of c-Myc facilitated senescence escape and cooperated with mutant activated FGFR2 in oncogenic transformation. The mechanism of oncogenic cooperation between mutant FGFR2 and c-Myc involved both c-Myc-facilitated senescence escape and protection against c-Myc-dependent apoptosis by FGFR2. Moreover, cells transformed by the combination of constitutively active FGFR2 and c-Myc become highly addicted to the prosurvival signaling of the mutant receptor, as these cells could be effectively eliminated by treatment with small molecule FGFR inhibitors. These studies provide insight into mechanisms underlying the differential effects of mutant FGFRs on cell proliferation and help define the properties of mutant FGFRs that make them highly oncogenic, but also susceptible to drug-induced cell death.
###end p 7
###begin title 8
RESULTS
###end title 8
###begin title 9
Birth defect and cancer-associated FGFR2 mutants induce senescence in primary cells
###end title 9
###begin p 10
###xml 5 10 5 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S252W</sup>
###xml 87 92 87 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K659E</sup>
###xml 209 210 209 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C5">5</xref>
###xml 211 212 211 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C7">7</xref>
###xml 224 229 224 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K659E</sup>
###xml 261 266 261 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K650E</sup>
###xml 377 378 377 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C3">3</xref>
###xml 511 516 511 516 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S252W</sup>
###xml 526 531 526 531 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K659E</sup>
###xml 621 626 621 626 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S252W</sup>
###xml 636 641 636 641 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K659E</sup>
###xml 844 848 841 845 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12V</sup>
###xml 983 987 980 984 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12V</sup>
###xml 1096 1097 1090 1091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP195F1">1</xref>
###xml 1286 1287 1277 1278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP195F1">1</xref>
###xml 1327 1332 1318 1323 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S252W</sup>
###xml 1342 1347 1333 1338 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K659E</sup>
###xml 1389 1393 1380 1384 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12V</sup>
###xml 1474 1475 1462 1463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP195F1">1</xref>
###xml 1528 1533 1516 1521 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K650E</sup>
###xml 1573 1578 1561 1566 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K659E</sup>
###xml 1793 1794 1781 1782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP195F1">1</xref>
###xml 563 568 <span type="species:ncbi:10090">mouse</span>
###xml 1351 1356 <span type="species:ncbi:9606">human</span>
FGFR2S252W, a mutation that affects ligand binding and causes Apert syndrome, and FGFR2K659E, a predicted constitutively active receptor mutated in the tyrosine kinase region, have been identified in cancers (5-7). The FGFR2K659E mutation is equivalent to FGFR3K650E, which is also found some cancers and causes the neonatal lethality syndrome Thanatophoric Dysplasia Type II (3). Because FGFRs signal through the PI3K and MAPK pathways, which both promote senescence when hyperactive, we examined whether FGFR2S252W and FGFR2K659E promoted senescence in primary mouse embryonic fibroblasts (MEFs). Wild-type FGFR2, FGFR2S252W and FGFR2K659E were introduced into primary MEFs at passage 2-3 using retroviral expression vectors, briefly drug selected, then stained for senescence-associated (sa) beta-galactosidase activity. Cells expressing RasG12V were used as positive controls in these experiments. In contrast to vector alone or wtFGFR2, expression of the FGFR2 mutants, like RasG12V, led to a significant increase in the number of cells that stained positive for sa-beta-galactosidase (Fig. 1A and B). sa-beta-Galactosidase staining corresponded to the appearance of many enlarged and multinucleated cells exhibiting a flattened morphology, and suppressed cell proliferation (Fig. 1A and C). Similarly, expression of FGFR2S252W and FGFR2K659E in human IMR90 lung fibroblasts, like RasG12V, led to an increase in the number of sa-beta-galactosidase-positive cells (Fig. 1E and F). A constitutively active FGFR3 mutant (FGFR3K650E) behaved essentially identical to FGFR2K659E in these assays (data not shown). The induction of senescence observed was associated with only a moderate increase in levels of the FGFR2 mutants compared with endogenous FGFR2 in MEFs and IMR90 fibroblasts (Fig. 1D and G). These results suggest that although birth defect and cancer-associated FGFR mutants generally promote proliferation and oncogenesis in immortal cells, they promote senescence in primary cells.
###end p 10
###begin p 11
###xml 52 53 52 53 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 163 164 160 161 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 287 288 281 282 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 427 428 421 422 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 520 521 514 515 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 634 635 625 626 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 787 788 775 776 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 879 880 863 864 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 900 901 883 884 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 574 579 <span type="species:ncbi:9606">human</span>
FGFR2 mutants promote senescence in primary cells. (A) Morphology (live cells and tubulin/DAPI stained cells) and sa-beta-galactosidase staining of primary MEFs. (B) The mean percentage of beta-galactosidase-positive cells and standard deviation based on three independent experiments. (C) Mean number of cell counts and standard deviation from passage 5 MEFs plated at 50 000 cells per dish (day 0) and counted every 2 days. (D) Western blots showing levels of FGFR2, phospho-ERK1/2 (T202/Y204) and total ERK in MEFs. (E) Live and sa-beta-galactosidase staining of primary human IMR90 fibroblasts expressing the indicated proteins. (F) Mean percentage of sa-beta-galactosidase-positive IMR90 cells and standard deviation based on triplicate samples from three independent experiments. (G) Western blot of IMR90 fibroblasts as in (D). Scale bars: live cells and sa-beta-gal-50 mum, tubulin/DAPI-10 mum.
###end p 11
###begin title 12
Activation of DNA-damage signaling by FGFR2 mutants
###end title 12
###begin p 13
###xml 275 280 275 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S252W</sup>
###xml 287 292 287 292 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K659E</sup>
###xml 299 303 299 303 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12V</sup>
###xml 516 521 516 521 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S252W</sup>
###xml 528 533 528 533 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K659E</sup>
###xml 540 544 540 544 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12V</sup>
###xml 685 686 681 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP195F2">2</xref>
###xml 812 814 808 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C35">35</xref>
###xml 959 960 947 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP195F2">2</xref>
###xml 1174 1176 1162 1164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C35">35</xref>
###xml 1353 1354 1341 1342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP195F2">2</xref>
###xml 1434 1435 1422 1423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP195F2">2</xref>
###xml 1452 1453 1440 1441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP195F3">3</xref>
We next investigated whether senescence caused by mutant FGFR2 proteins is related to DNA-damage signaling and activation of DNA-damage checkpoints that promote cell cycle arrest. Primary MEFs and IMR90 fibroblasts subjected to retroviral expression of wild-type FGFR2, FGFR2S252W, FGFR2K659E or RasG12V at passage 3 were examined for several proteins that participate in the DNA-damage response at passage 5. When compared with control cells infected with empty vector or wild-type FGFR2, expression of either FGFR2S252W, FGFR2K659E or RasG12V resulted in an increased percentage of cells exhibiting the characteristic speckled pattern of gammaH2AX (Ser139-phosphorylated H2AX) (Fig. 2A and B), an alternative histone that associates with Ataxia telangiectasia mutated (ATM) and accumulates at DNA-damage foci (35). IMR90 fibroblasts similarly showed increased gammaH2AX staining and gammaH2AX staining co-localized with serine 1981-phosphorylated ATM (Fig. 2C-E). Very similar results were achieved when MEFs and IMR90 fibroblasts were stained with antiserum directed against phosphorylated (Ser25) 53BP1 (), a p53 interacting protein activated in response to DNA damage (35). Further, immunoblot analysis showed increased DNA damage-associated phosphorylation of Chk2, p53BP1 and p53 in IMR90 fibroblasts expressing mutant FGF receptors or Ras (Fig. 2D). In addition, levels of p53, p21 and p16 were increased in these cells (Fig. 2D, also see Fig. 3D), a result consistent with activation of the DNA-damage checkpoint and suppressed proliferation and/or senescence. Finally, levels of trimethylated (K9) Histone H3, a marker of silenced (hetero) chromatin, were increased by the expression of mutant FGF receptors and Ras.
###end p 13
###begin p 14
###xml 52 53 52 53 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 331 332 319 320 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 438 439 422 423 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 542 543 522 523 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 850 851 826 827 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 946 951 918 923 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S252W</sup>
###xml 960 965 932 937 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K569E</sup>
###xml 981 982 953 954 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
Induction of DNA-damage response by FGFR2 mutants. (A) gammaH2AX immunoflourescense in primary MEFs expressing the indicated proteins. Low and higher magnification views are provided to show both the general increase in the number of cells staining for gammaH2AX, and the speckled pattern of gammaH2AX staining in positive cells. (B) Mean percentage of gammaH2AX-positive MEFs with standard deviation from three independent experiments. (C) gammaH2AX and p(ser1981)-ATM staining in IMR90 cells expressing the same set of proteins as in (A). (D) Mean percentage of gammaH2AX- and pATM-positive (cells showing co-localization) IMR90 fibroblasts with standard deviations calculated from three independent experiments. Hydrogen peroxide treated cells were used as a positive control, and DAPI staining was used to visualize nuclei in these experiments. (E) gammaH2AX and pATM staining showing coincident staining in IMR90 fibroblasts expressing FGFR2S252W or FGFR2K569E as indicated. (F) Immunoblot analysis of the indicated proteins. Residues recognized by phospho-specific antiserums is indicated. Actin was used as a general loading control. Scale bars: all are 50 microm, except 'high' (magnification) which is 10 microm.
###end p 14
###begin p 15
###xml 89 90 89 90 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 253 254 250 251 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 401 402 395 396 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 639 640 633 634 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 795 796 788 789 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
Suppression of mutant FGFR2-induced senescence by coexpression of c-Myc or loss of p53. (A) sa-beta-Galactosidase staining of cells infected with retroviruses expressing the indicated proteins in wild-type MEFs, p53-null MEFs or MEFs expressing c-Myc. (B) Mean percentage and standard deviation of sa-beta-galactosidase-positive cells for infected wild-type MEFs and MEFs expressing exogenous c-Myc. (C) The average number of population doublings calculated during successive cell passages for the various cell strains expressing c-Myc. Data are from two independent experiments performed in triplicate and standard deviations are shown. (D) Immunoblot analysis of DNA damage and senescence markers in primary wild-type MEFs and p53-null MEFs expressing the indicated proteins. Scale bars: 50 mum.
###end p 15
###begin p 16
###xml 31 36 31 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K659E</sup>
###xml 145 150 145 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S252W</sup>
###xml 189 193 189 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12V</sup>
###xml 200 201 200 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP195F2">2</xref>
###xml 291 292 291 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP195F1">1</xref>
The constitutively active FGFR2K659E mutant was generally more effective at inducing DNA-damage foci and senescence-associated markers than FGFR2S252W, but not as effective as oncogenic RasG12V (Fig. 2A-D), a result that generally correlated with their abilities to promote senescence (Fig. 1).
###end p 16
###begin title 17
Senescence induced by mutant FGFRs can be bypassed by increased Myc or loss of p53
###end title 17
###begin p 18
###xml 47 49 47 49 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C34">34</xref>
###xml 173 174 173 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP195F2">2</xref>
###xml 195 196 195 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP195F3">3</xref>
###xml 330 335 330 335 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S252W</sup>
###xml 342 347 342 347 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K659E</sup>
###xml 355 359 355 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12V</sup>
###xml 496 498 493 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C28">28</xref>
###xml 504 508 501 505 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12V</sup>
###xml 597 602 594 599 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S252W</sup>
###xml 611 616 608 613 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K659E</sup>
###xml 724 725 718 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP195F3">3</xref>
###xml 875 876 869 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP195F3">3</xref>
###xml 883 886 877 880 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
###xml 938 940 932 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C37">37</xref>
###xml 1060 1061 1054 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP195F3">3</xref>
The well-documented role of p53 in senescence (34) and the apparent activation of p53 and p53 targets associated with senescence by FGFR2 mutants in IMR90 fibroblasts (Fig. 2F) and in MEFs (Fig. 3D), suggested that p53 might be playing a critical role in the senescence observed. To examine the role of p53, wild-type FGFR2, FGFR2S252W, FGFR2K659E and RasG12V were expressed in p53-null MEFs at passage 5 and cells stained for sa-beta-galactosidase activity at passage 7. As previously reported (28), RasG12V-induced senescence was dependent on p53. Likewise, p53-null MEFs expressing either FGFR2S252W or FGFR2K659E failed to undergo proliferation arrest (data not shown) and showed no sa-beta-galactosidase activity (Fig. 3A). Consistence with the abrogated senescence response in p53-null MEFs, p21 and p16 levels were not increased by mutant FGFRs or oncogenic Ras (Fig. 3D). p19ARF levels were elevated in p53-null MEFs as expected (37) and were further increased through a p53-independent mechanism by the expression of mutant FGF receptors or Ras (Fig. 3D).
###end p 18
###begin p 19
###xml 133 135 133 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C38">38</xref>
###xml 209 211 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C39">39</xref>
###xml 254 256 254 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C40">40</xref>
###xml 370 374 370 374 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12V</sup>
###xml 381 382 381 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP195F3">3</xref>
###xml 634 635 631 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP195F3">3</xref>
Another potentially important factor involved in senescence is c-Myc. c-Myc is required for sustained proliferation of primary MEFs (38), as well as for susceptibility of fibroblasts to transformation by Ras (39), and is downregulated during senescence (40). Indeed, we found c-Myc protein and RNA levels were downregulated in primary MEFs expressing FGFR mutants or RasG12V (Fig. 3D and data not shown), a result consistent with the increased sa-beta-galactosidase activity and decreased proliferation observed with these cells. In contrast, p53-null MEFs failed to downregulate c-Myc levels in response to mutant FGFRs or Ras (Fig. 3D).
###end p 19
###begin p 20
###xml 286 290 286 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12V</sup>
###xml 447 448 444 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP195F3">3</xref>
###xml 619 620 613 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP195F3">3</xref>
###xml 819 820 810 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP195F3">3</xref>
###xml 1161 1162 1152 1153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP195F3">3</xref>
To examine the role of c-Myc downregulation in mediating growth arrest and senescence caused by mutant FGFR, primary MEFs at passage 2 were first generated to express ectopic c-Myc, and subsequently infected with control virus or viruses expressing wild-type FGFR2, FGFR2 mutants or RasG12V at passage 4. Drug-selected populations were replated, grown for 5 days and then stained for sa-beta-galactosidase activity. Ectopic c-Myc expression (Fig. 3D) was found to be effective at reducing the otherwise elevated number of sa-beta-galactosidase-positive cells caused by the expression of mutant FGFRs or Ras alone (Fig. 3A and B). Additionally, the sa-beta-galactosidase-positive cells found in these populations generally did not exhibit the highly enlarged and often multinucleated morphology of senescent cells (Fig. 3A). Finally, when compared with vector control cells or cells expressing c-Myc alone, cells co-expressing c-Myc with either the mutant FGFRs or Ras showed elevated proliferation during a period when MEFs typically undergo senescence. However, the proliferated rate of these cells was reduced compared with pre-senescent wild-type MEFs (Fig. 3C), suggesting that ectopic Myc only partially overcomes senescence-associated proliferative arrest.
###end p 20
###begin p 21
###xml 30 32 30 32 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C41">41</xref>
###xml 197 198 197 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP195F3">3</xref>
###xml 281 285 281 285 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12V</sup>
###xml 470 474 470 474 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12V</sup>
###xml 568 569 568 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP195F3">3</xref>
###xml 807 809 807 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C41">41</xref>
Similar to a previous report (41), forced expression of c-Myc alone in primary MEFs had an initial toxic effect, as reflected in a reduction in cell number compared with vector control cells (Fig. 3C), The continued proliferation of cells expressing c-Myc plus FGFR2 mutants or RasG12V indicates that these proteins at least partially negate Myc-dependent toxicity. c-Myc expression in turn appears to facilitate senescence rescue of MEFs expressing FGFR2 mutants or RasG12V by overriding the effects of p53, p21 and p16, which remain upregulated in these cells (Fig. 3D). However, continued p53 expression in MEFs expressing ectopic c-Myc appears to play a role in the Myc-dependent toxicity, since little or no toxicity was observed when c-Myc was overexpressed in p53-null MEFs (data not shown, also see 41).
###end p 21
###begin p 22
###xml 162 166 162 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12V</sup>
###xml 188 192 188 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12V</sup>
Taken together, these results suggest that while c-Myc expression facilitates escape from growth arrest/senescence caused by the expression of mutant FGFRs or RasG12V, FGFR2 mutants or RasG12V partially rescues p53-dependent toxicity caused by forced c-Myc expression.
###end p 22
###begin title 23
c-Myc and constitutively active FGFR2 cooperate in oncogenic transformation
###end title 23
###begin p 24
###xml 359 364 359 364 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K659E</sup>
###xml 373 378 373 378 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S252W</sup>
###xml 548 553 548 553 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K659E</sup>
###xml 562 567 562 567 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S252W</sup>
###xml 649 654 649 654 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K659E</sup>
###xml 697 702 697 702 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S252W</sup>
###xml 751 752 751 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP195F4">4</xref>
###xml 798 803 798 803 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K659E</sup>
###xml 857 858 857 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP195F4">4</xref>
###xml 940 945 940 945 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S252W</sup>
###xml 1000 1001 1000 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP195F4">4</xref>
###xml 1106 1111 1106 1111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K659E</sup>
###xml 1120 1124 1120 1124 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12V</sup>
###xml 1155 1160 1155 1160 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S252W</sup>
###xml 906 910 <span type="species:ncbi:10090">mice</span>
###xml 1032 1036 <span type="species:ncbi:10090">mice</span>
The ability of c-Myc to promote escape from mutant FGFR2-induced senescence raised the possibility that c-Myc and mutant FGFRs may cooperate in oncogenic transformation. To test this, we first performed focus formation assays. MEFs at passage 5 previously infected with c-Myc retrovirus were infected with virus expressing vector alone, wild-type FGFR2, FGFR2K659E or FGFR2S252W. Infected cells were plated at equal density and stained with methylene blue two weeks later. In contrast to vector control and wild-type FGFR2, MEFs infected with FGFR2K659E or FGFR2S252W both gave rise to dense foci of morphologically transformed cells. However, FGFR2K659E was consistently more effective than FGFR2S252W in cooperating with c-Myc in these assays (Fig. 4A and B). Whereas cells transformed with FGFR2K659E plus c-Myc formed colonies in soft agar assays (Fig. 4C) and formed tumors when injected into athymic mice (4/4), cells expressing FGFR2S252W plus c-Myc neither formed colonies in soft agar (Fig. 4C) or formed tumors in athymic mice (0/4). In addition, when introduced into primary p53-null MEFs, FGFR2K659E (and RasG12V) was more effective than FGFR2S252W or wild-type FGFR2 in causing morphological transformation, foci formation and colony-forming ability in soft agar (not shown). Finally, consistent with results showing that c-Myc partially rescued senescence caused by the FGFR2 mutants, morphologically transformed cells derived from focus formation assays showed no indications of senescence and proliferated continuously for greater than 10 passages at a high rate (not shown).
###end p 24
###begin p 25
###xml 81 82 81 82 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 109 110 109 110 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 138 139 138 139 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
Constitutively activated FGFR2 cooperates with Myc in oncogenic transformation. (A) Focus formation assays, (B) live cell morphology and (C) colony formation assays in soft agar with primary MEFs infected with retroviruses expressing the indicated proteins or combinations of proteins.
###end p 25
###begin p 26
###xml 35 40 35 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S252W</sup>
###xml 50 55 50 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K659E</sup>
###xml 230 235 230 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K659E</sup>
###xml 267 272 267 272 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S252W</sup>
The differential abilities of FGFR2S252W and FGFR2K659E to cause malignant transformation in cooperation with c-Myc, or in the absence of p53, likely reflect the different mechanisms responsible for their activation; whereas FGFR2K659E is constitutively active, FGFR2S252W activation remains dependent on ligand binding, and FGF ligands may be limiting in our growth conditions.
###end p 26
###begin title 27
Cooperation between constitutively active FGFR2 and Myc relies on prosurvival activities of the mutant receptor
###end title 27
###begin p 28
###xml 125 127 125 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C42">42</xref>
###xml 128 130 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C43">43</xref>
###xml 234 235 234 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP195F3">3</xref>
###xml 290 291 290 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP195F4">4</xref>
###xml 483 487 483 487 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12V</sup>
###xml 707 709 707 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C44">44</xref>
###xml 1271 1272 1271 1272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP195F5">5</xref>
###xml 1320 1325 1320 1325 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S252W</sup>
###xml 1427 1428 1427 1428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP195F5">5</xref>
###xml 1443 1448 1443 1448 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K569E</sup>
###xml 1648 1653 1648 1653 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K569E</sup>
###xml 1721 1722 1721 1722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP195F5">5</xref>
###xml 1747 1752 1747 1752 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K569E</sup>
###xml 1762 1767 1762 1767 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S252W</sup>
###xml 1849 1850 1849 1850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP195F5">5</xref>
###xml 1960 1965 1960 1965 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K569E</sup>
###xml 2037 2041 2037 2041 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12V</sup>
###xml 2234 2235 2234 2235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP195F5">5</xref>
###xml 2450 2454 2450 2454 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12V</sup>
###xml 2463 2468 2463 2468 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K569E</sup>
###xml 536 542 <span type="species:ncbi:9913">bovine</span>
It is well-established that forced Myc expression can sensitize cells, particularly primary cells, to apoptosis (reviewed in 42,43). Therefore the ability of FGFR2 mutants to suppress toxicity caused by ectopic c-Myc expression (Fig. 3C) and cooperate with Myc in cell transformation (Fig. 4) raised the possibility that they do this at least in part by suppressing Myc-dependent apoptosis. To test this, MEFs coexpressing c-Myc alone or c-Myc plus the FGFR2 mutants, wtFGFR2, or RasG12V were subjected to serum deprivation (0.1% fetal bovine serum-FBS), conditions in which forced c-Myc expression causes apoptosis. Simultaneous with serum deprivation, cells were treated with the FGFR inhibitor PD173074 (44) or DMSO vehicle control. Apoptosis was evaluated by fluorescence-activated cell sorting (FACS) of cells stained with AnnexinV antiserum and the DNA intercalator 7-AAD to distinguish early apoptotic cells (AnnnexinV-positive, 7-AAD-negative) and late apoptotic cells (AnnexinV- positive and 7-AAD-positive). In the absence of FGFR inhibition (DMSO vehicle alone), c-Myc expression significantly increased apoptosis compared to vector-infected MEFs as expected, and apoptosis was further increased by suppression of endogenous FGFR signaling with PD173074 (Fig. 5A and C). Expression of wild-type FGFR2 or FGFR2S252W provided protection against Myc-dependent apoptosis that was lost upon treatment with PD173074 (Fig. 5A and C). FGFR2K569E also provided some protection against c-Myc-dependent apoptosis (that did not reach statistical significance), but strikingly, in the presence of PD173074, nearly all cells expressing c-Myc and FGFR2K569E had undergone apoptosis within 14 hours of serum deprivation (Fig. 5A-C). Expression of FGFR2K569E (or FGFR2S252W) had little effect on apoptosis in the absence of ectopic c-Myc expression (Fig. 5A and data not shown), demonstrating that the high level of apoptosis that occurs in the presence of the FGFR2K569E plus c-Myc is dependent on both the mutant FGFR and c-Myc. Finally, RasG12V provided modest, but not statistically significant, protection against Myc-dependent apoptosis, and apoptosis was not significantly increased when these cells were treated with PD173074 (Fig. 5A-C). The latter results are consistent with Ras operating downstream of FGFRs. Moreover, both the MEK inhibitor PD98059 and the PI3K inhibitor LY294002 were effective at abrogating the prosurvival activities of RasG12V or FGFR2K569E in cells that coexpressed ectopic c-Myc (not shown).
###end p 28
###begin p 29
###xml 47 48 47 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 493 494 493 494 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 611 612 611 612 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 749 750 749 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 765 766 765 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 883 888 883 888 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K659E</sup>
###xml 1027 1028 1027 1028 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1281 1286 1277 1282 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K659E</sup>
###xml 1332 1333 1328 1329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Prosurvival activity of FGF receptor mutants. (A) MEFs expressing the indicated proteins were subjected to serum deprivation (0.1% FBS) plus DMSO vehicle or FGFR inhibitor PD173074 for 14 h. Cells were stained with AnnexinV and 7AAD and the percentage of AnnexinV-positive apoptotic cells (right-side quadrants) and 7AAD stained cells (lysed/dead cells-upper quadrants) determined by FAC sorting. Data shown are representative of at least two independent experiments performed in triplicate. (B) Live cell images showing the response of the indicated cell lines to serum deprivation with and without PD173074. (C) Bar graph showing mean percentage of AnnexinV-positive cells present following serum-deprivation and either DMSO vehicle or PD173074. *P < 0.005 and **P < 0.0005 for the specific comparisons indicated. Note that the percentage of apoptotic cells observed with the FGFR2K659E plus c-Myc strain treated with PD173074 was significantly greater than in any of the other cell strains tested in this experimental set. (D) MEFs expressing the indicated proteins grown in 10% FBS were subjected to DMSO vehicle or FGFR inhibitor PD173074 treatment at either 1.25 or 5 microM and analyzed for apoptosis as described above. The number of apoptotic cells in the expressing FGFR2K659E plus c-Myc strain was significantly greater (P < 0.0005) than any of the other experimental settings shown in (D).
###end p 29
###begin p 30
###xml 308 309 304 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP195F5">5</xref>
###xml 332 337 328 333 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S252W</sup>
###xml 464 465 460 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP195F5">5</xref>
###xml 493 498 489 494 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K569E</sup>
###xml 621 622 617 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP195F5">5</xref>
###xml 664 668 660 664 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12V</sup>
###xml 739 740 735 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP195F5">5</xref>
To further investigate the effect of mutant FGFRs on c-Myc-dependent apoptosis, experiments were repeated under normal serum levels (10%) using two different concentrations of PD173074 (1.25 or 5 microM). MEFs expressing c-Myc alone showed relatively low levels of apoptosis in the presence of vehicle (Fig. 5D). wild-type and FGFR2S252W had a modest, but not statistically significant, protective effect against apoptosis that was lost with FGFR inhibition (Fig. 5D). The combination of FGFR2K569E plus c-Myc exhibited less apoptosis than c-Myc alone, but treatment with PD173074 induced a high level of apoptosis (Fig. 5D). FGFR inhibition in MEFs expressing RasG12V plus c-Myc again had little or no effect on levels of apoptosis (Fig. 5D).
###end p 30
###begin p 31
###xml 212 217 212 217 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K569E</sup>
Taken together, these results indicate that mutant hyperactive FGFR2 signaling generally has a protective effect against Myc-dependent apoptosis and that MEFs oncogenically transformed by the combination of FGFR2K569E plus c-Myc appear to become highly addicted to the prosurvival activities of the mutant receptor and, as a result, highly susceptible to apoptosis when subjected to FGFR inhibition.
###end p 31
###begin p 32
###xml 97 102 97 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K659E</sup>
###xml 292 293 292 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP195F6">6</xref>
###xml 403 408 403 408 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K659E</sup>
###xml 686 691 686 691 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S252W</sup>
###xml 709 710 709 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP195F6">6</xref>
###xml 884 888 884 888 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12V</sup>
###xml 906 907 906 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP195F6">6</xref>
###xml 907 909 907 909 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">).</bold>
Consistent with the powerful pro-apoptotic effect that PD173074 had on cells transformed by FGFR2K659E plus c-Myc, FGFR signaling was strongly and rapidly suppressed by PD173074 treatment (2 h) in these cells, as indicated by the activation state of ERK1/2 and, to a lesser extent, Akt (Fig. 6). In contrast, PD173074 had only a weak inhibitory effect on ERK and Akt activation in cells expressing FGFR2K659E alone, consistent with the notion that when expressed together with Myc, cells develop an increased dependence on the mutant receptor for ERK activation and survival. PD173074 also had only a weak inhibitory effect on ERK and Akt activation in cells expressing wtFGFR2 or FGFR2S252W plus c-Myc (Fig. 6), a result consistent with the low levels of apoptosis induced in these cells. As expected, phosphorylation of Erk and Akt was not altered by PD173074 in MEFs expressing RasG12V plus c-Myc (Fig. 6).
###end p 32
###begin p 33
Immunoblot analysis of FGFR signaling in cells treated with PD173074. MEFs expressing the indicated proteins were treated with DMSO vehicle (O) or a titration of PD173074 (1.25, 2.5, 5 and 10 microM) for 2 h. Cell lysates were analyzed for expression of the indicated proteins. pAKT-pSer473.
###end p 33
###begin p 34
###xml 118 123 118 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K659E</sup>
###xml 281 283 281 283 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">XL</sub>
###xml 329 334 329 334 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K659E</sup>
###xml 356 357 356 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP195F6">6</xref>
###xml 488 490 488 490 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">XL</sub>
###xml 532 537 532 537 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K659E</sup>
###xml 184 188 <span type="species:ncbi:9696">Puma</span>
###xml 475 479 <span type="species:ncbi:9696">Puma</span>
In addition to inactivation of ERK, the high level of apoptosis caused by PD173074 treatment of cells expressing FGFR2K659E plus c-Myc was associated with modestly increased levels of Puma, a pro-apoptotic protein encoded by a p53 target gene and lower levels of anti-apoptotic BclXL protein than in cells expressing either FGFR2K659E or c-Myc alone (Fig. 6). Although p53 levels appeared to not directly correspond to levels of apoptosis, the unique combination of elevated Puma, low BclXL and loss of ERK in cells expressing FGFR2K659E plus c-Myc may contribute to the high level of apoptosis observed with these cells.
###end p 34
###begin title 35
###xml 38 43 38 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K659E</sup>
Apoptosis of MEFs transformed by FGFR2K659E plus c-Myc triggered by PD173074 is p53-dependent
###end title 35
###begin p 36
###xml 107 112 107 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K659E</sup>
###xml 233 238 233 238 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K659E</sup>
###xml 311 316 311 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K659E</sup>
###xml 508 513 508 513 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K659E</sup>
###xml 560 565 560 565 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K659E</sup>
###xml 714 715 714 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP195F7">7</xref>
###xml 843 848 843 848 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K659E</sup>
###xml 855 856 855 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP195F7">7</xref>
We next directly tested whether the robust apoptosis caused by PD173074 treatment of cells expressing FGFR2K659E plus c-Myc was p53-dependent. p53-null MEFs were infected with c-Myc retrovirus, drug selected, then infected with FGFR2K659E retrovirus and drug selected. Similar to wild-type MEFs expressing FGFR2K659E plus c-Myc, these cells were capable of forming foci of morphologically transformed cells and growth in soft agar (data not shown). However, in contrast to wild-type MEFs transformed by FGFR2K659E plus c-Myc, p53-null MEFs transformed by FGFR2K659E plus c-Myc showed little or no apoptosis following PD173074 treatment, either in medium containing 10% FBS or under serum-deprived conditions (Fig. 7A and B). The loss of sensitivity to PD173074 in these cells occurred despite the presence of elevated levels of c-Myc and FGFR2K659E (Fig. 7C).
###end p 36
###begin p 37
###xml 80 85 80 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K569E</sup>
###xml 105 106 105 106 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 192 197 192 197 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K569E</sup>
###xml 529 530 525 526 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 534 535 530 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 599 600 595 596 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 642 647 638 643 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K569E</sup>
###xml 771 776 <span type="species:ncbi:9606">human</span>
Apoptosis caused by FGFR inhibition in MEFs expressing exogenous c-Myc and FGFR2K569E is p53 dependent. (A) Primary MEFs and p53-null MEFs, both transformed by co-expression of c-Myc and FGFR2K569E, were treated with DMSO vehicle or 1.25 microM PD173074 in medium containing 10% FBS or in medium containing 0.1% FBS for 14 h. The percentage of AnnexinV and 7AAD positive cells was determined by FACS analysis. Assays were performed in triplicate and mean percentage of total apoptotic cells with standard deviation are shown in (B). *P < 0.0005 when compared with comparably treated p53-null MEFs. (C) Western blot showing expression of FGFR2K569E and c-Myc in the indicated cell lines. The dash indicates endogenous c-Myc and the asterisk indicates the slightly smaller human c-Myc protein that was introduced.
###end p 37
###begin title 38
DISCUSSION
###end title 38
###begin p 39
###xml 512 513 512 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C6">6</xref>
###xml 514 515 514 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C7">7</xref>
###xml 897 899 897 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C45">45</xref>
###xml 1247 1249 1247 1249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C46">46</xref>
###xml 1326 1328 1326 1328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C47">47</xref>
###xml 1465 1467 1465 1467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C36">36</xref>
Our results further define the oncogenic activities of mutant activated FGFRs by showing that they promote DNA-damage-associated senescence and that events such as loss of p53 or Myc deregulation suppress their senescence-promoting activity and promote oncogenic conversion. Previous studies using immortal and cancer-derived cell lines indicated that the oncogenic activity of cancer-associated FGFR mutants is associated with both their ability to promote cell proliferation and to exert prosurvival activity (6,7, data not shown). The intrinsic ability of mutant FGFRs to stimulate cell proliferation, together with our finding that they promote DNA-damage signaling, is consistent with models of oncogene-induced 'hyperproliferative stress', in which excessive proliferation signaling is thought to compromise the integrity of DNA replication and lead to the development of DNA strand breaks (45). However, although generally consistent with this model, it remains to be shown that hyperproliferation signaling mediated by mutant FGFRs leads to DNA strand breaks. In addition to DNA-damage signaling, senescence has been linked to several other mechanisms (which may not be mutually exclusive), including the induction of ER stress signaling (46), Sprouty upregulation and negative feedback signaling in the MAPK pathway (47), senescence-associated heterochromatin formation (SAHF), production of reactive oxygen species (ROS) and telomere erosion (reviewed in 36). Although we cannot rule out that ROS and telomere erosion may be involved in DNA-damage signaling and senescence observed in this study, we did not consistently observe induction of Sprouty or ER stress markers in MEFs or IMR90 fibroblasts expressing mutant FGFR2 (data not shown). However, we did observe increased levels of trimethylated (K9) Histone H3, a potential indication that SAHF cooperates with, or is a byproduct of activation of DNA-damage signaling by these oncogenic proteins.
###end p 39
###begin p 40
###xml 165 169 165 169 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12V</sup>
###xml 656 658 656 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C38">38</xref>
###xml 659 661 659 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C48">48</xref>
###xml 1108 1110 1108 1110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C49">49</xref>
###xml 1111 1113 1111 1113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C50">50</xref>
###xml 1209 1210 1209 1210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP195F3">3</xref>
Another mechanism that might contribute to the induction of senescence is c-Myc downregulation. Senescence induced by the expression of FGFR2 mutants, as well as RasG12V, led to c-Myc downregulation, and coexpression of Myc with these proteins facilitated senescence escape. The decreased levels of c-Myc in primary cells may be an indirect consequence of cells exiting the cell cycle and becoming senescent. Alternatively, DNA-damage signaling or other signaling events activated by oncogenic Ras or FGFR2 mutants in primary cells may serve to more directly downregulate c-Myc. Since c-Myc is essential for sustained proliferation of primary fibroblasts (38,48), its downregulation in this setting likely directly contributes to cell cycle exit and senescence. Our results therefore raise the possibility that the diminished or abrogated senescence response typical of immortal and cancer cells may in part reflect the acquisition of oncogenic events that prevent proper downregulation of Myc. This idea is consistent with results showing that conditional inactivation of Myc in tumors triggers senescence (49,50). Moreover, the finding that c-Myc levels are elevated in early passage MEFs lacking p53 (Fig. 3D), raises the possibility that c-Myc upregulation in this setting constitutes a critical and perhaps general mechanism underlying senescence escape and oncogenic progression associated with loss of p53.
###end p 40
###begin p 41
###xml 411 413 411 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C42">42</xref>
###xml 414 416 414 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C43">43</xref>
###xml 816 821 816 821 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K569E</sup>
###xml 1249 1254 1249 1254 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K659E</sup>
###xml 1369 1374 1369 1374 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K569E</sup>
###xml 2107 2112 2107 2112 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K569E</sup>
Although suppression of mutant FGFR2-induced senescence by exogenous Myc expression appears to be an important mechanism contributing to their oncogenic cooperation, suppression of Myc-driven apoptosis by hyperactive FGFR signaling may be equally important. A number of different oncogenic proteins that are strongly mitogenic sensitize cells to apoptosis, with Myc being the prototypical member of this group (42,43). Both the mitogenic and pro-apoptotic activity of Myc is enhanced by constitutive and/or high-level expression of c-Myc protein, a common feature of tumor cells. Accordingly, the mitogenic and oncogenic activities of deregulated Myc expression are linked to events that function to suppress Myc's pro-apoptotic activity, such as loss of p53. Our results suggest that the constitutively active FGFR2K569E mutant cooperates with forced Myc expression in oncogenic transformation in part by suppressing Myc-dependent apoptosis. Further, the striking sensitivity of these cells to apoptosis induced by FGFR inhibition, which was far greater than that caused by c-Myc expression alone, suggests that they develop an addiction to the prosurvival activities of the mutant receptor. Interestingly, the sensitivity of cells expressing FGFR2K659E plus c-Myc to apoptosis was linked to robust inactivation of ERK1/2, which did not occur in cells expressing FGFR2K569E alone. One possible explanation for this result is that constitutively active FGF receptor signaling may be prone to co-op, replace or otherwise downregulate the activities of overlapping signaling pathways that contribute to ERK activation and normally provide pro-survival signaling. Such a tendency would be predicted to make cells more dependent on the mutant receptor for ERK activation and associated prosurvival signaling, but would be driven and manifest only in the presence of strong pro-apoptotic activity, such as that caused by constitutively high Myc expression. Although the underlying mechanisms responsible for the development of oncogene addiction or co-dependency in general, and in cells expressing Myc and FGFR2K569E in particular, remain unclear, these cells may offer a useful model for dissecting this phenomenon.
###end p 41
###begin p 42
###xml 24 29 24 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K569E</sup>
###xml 158 163 158 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S252W</sup>
###xml 285 290 285 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K569E</sup>
###xml 331 336 331 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S252W</sup>
###xml 438 443 438 443 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S252W</sup>
###xml 562 563 562 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C6">6</xref>
###xml 564 565 564 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C7">7</xref>
###xml 566 568 566 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C51">51</xref>
###xml 682 687 682 687 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S252W</sup>
###xml 881 886 881 886 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S252W</sup>
###xml 1166 1171 1166 1171 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S252W</sup>
###xml 1181 1186 1181 1186 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S253W</sup>
###xml 1507 1512 1507 1512 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S252W</sup>
The combination of FGFR2K569E and c-Myc created highly oncogenic cells susceptible to apoptotic elimination by FGFR inhibition, whereas cells expressing FGFR2S252W plus c-Myc were neither tumorigenic nor vulnerable to apoptosis. This difference in susceptibility is likely due to FGFR2K569E being constitutively activated and FGFR2S252W being largely dependent on ligand binding. Interestingly, endometrial tumor cells containing an FGFR2S252W mutation and gastric tumors with FGFR2 amplification were highly susceptible to apoptosis when treated with PD173074 (6,7,51). Although it is not clear why these tumor cells are more sensitive to FGFR inhibition than MEFs expressing FGFR2S252W plus c-Myc, it may be related to cell type-specific differences in endogenous levels of FGF ligand(s) that the mutant receptor requires for full activation. Because aberrant activation of FGFR2S252W is related primarily to its broadened ligand-binding specificity and increased ligand-binding affinity, its pathological activities must necessarily be linked to local or cell-intrinsic ligand levels. Therefore, the ligand-dependent nature of Apert syndrome mutations, like FGFR2S252W and FGFR2S253W, together with a requirement for additional cooperating events like Myc deregulation or loss of p53 that suppress senescence, suggests that their oncogenic potential is less likely to be realized than constitutively activated mutant receptors. Moreover, the multiple events needed to elicit oncogenic activity from FGFR2S252W may explain why Apert syndrome is not associated with a strong predisposition to cancer.
###end p 42
###begin p 43
###xml 159 160 159 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C6">6</xref>
###xml 161 162 161 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C7">7</xref>
###xml 163 165 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C51">51</xref>
###xml 502 504 502 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C50">50</xref>
Although it is clear that FGFR inhibition can induce apoptosis in cells derived from some tumors containing FGFR2 (and FGFR3) mutations or gene amplification (6,7,51), the underlying mechanism remains unclear. Our results suggest that their vulnerability is likely dependent on an additional event(s) that has latent pro-apoptotic activity, such as Myc deregulation. Interestingly, not all gastric tumor-derived cell lines containing amplified FGFR2 respond to FGFR inhibition by undergoing apoptosis (50). Instead, some respond by exiting from the cell cycle, a result consistent with the tumor cells becoming dependent on the proliferation-associated activities of the mutant or amplified receptors. Thus, it might be informative to screen gastric and endometrial tumor cells that have FGFR2 mutations or gene amplification for alterations at Myc loci (e.g. gene amplification), and then determine whether their sensitivity to apoptosis (versus blocked proliferation) by FGFR inhibition is related to, or dependent on, Myc deregulation. Defining these relationships may more precisely identify tumors particularly susceptible to apoptotic elimination by small molecule FGFR inhibitors.
###end p 43
###begin title 44
MATERIALS AND METHODS
###end title 44
###begin title 45
Expression plasmids
###end title 45
###begin p 46
###xml 81 86 81 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K659E</sup>
###xml 98 102 98 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12V</sup>
###xml 128 133 128 133 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S252W</sup>
###xml 167 171 167 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12V</sup>
Retroviral expression plasmids used included pFBneo-wtFGFR2c (Bek), pFBneo-FGFR2cK659E, pFBneo-RasG12V, pFBneo-GFP, pLXSN-FGFR2cS252W, pBABEpuro-c-Myc, pBABEpuro-H-RasG12V. Ecotropic retroviruses were produced in Ecopack 2 293 cells (Clonetech), and amphotropic retroviruses were generated in Phoenix cells following the manufacturers' protocols.
###end p 46
###begin title 47
Cells, cell culture and retroviral infection
###end title 47
###begin p 48
###xml 137 139 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C39">39</xref>
###xml 404 406 404 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C38">38</xref>
###xml 45 50 <span type="species:ncbi:10090">mouse</span>
###xml 101 105 <span type="species:ncbi:9913">calf</span>
Primary MEF cultures were derived from E13.5 mouse embryos and cultured in DMEM containing 10% fetal calf serum as described previously (39). IMR-90 (American Type Culture Collection) and Ecopack 2 293 cells (Clontech) were cultured in DMEM (Invitrogen) supplemented with 10% FBS (Hyclone). Stable retroviral infections of IMR-90 (ATCC), C3H10T1/2 (ATCC) and MEFs were performed as previously described (38). For sequential infections, cells were infected with the second virus 2-3 days following the initial infection. Selection with puromycin (1.5 microg/ml) or geneticin (1 mg/ml) was done after all rounds of infection.
###end p 48
###begin title 49
Senescence, transformation, tumor formation and apoptosis assays
###end title 49
###begin p 50
###xml 75 80 72 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 83 85 80 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C29">29</xref>
###xml 165 167 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C39">39</xref>
###xml 225 230 222 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxn1</italic>
###xml 230 232 227 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nu</italic>
###xml 230 232 227 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>nu</italic></sup>
###xml 313 314 310 311 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 214 223 <span type="species:ncbi:10090">nude mice</span>
Staining for sa-beta-galactosidase activity was performed as described Lin et al. (29). Soft agar and focus formation assays were performed as previously described (39). For tumor formation assays, 8-week-old male nude mice (Foxn1nu Jackson Labs) were injected subcutaneously into their shoulder flank with 2 x 106 cells. Tumors were not allowed to get > 2 cm in diameter as required by OHSU IACUC guidelines.
###end p 50
###begin p 51
###xml 228 229 224 225 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 428 429 420 421 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 608 615 600 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">De Novo</italic>
For apoptosis assays, subconfluent cells were plated at 200 000 cells per 35 mm dish into growth media containing (10% FBS) for 24 h. FGFR inhibitor PD173074 (Calbiochem) was added at concentrations ranging from 1.25 to 10 microm (in DMSO vehicle) in either 10% FBS medium or in medium replaced to contain 0.1% FBS. PI3K inhibitor LY294002 (Cell Signaling Technology) and MEK inhibitor PD98059 (Calbiochem) were used at 50 microm. Cells were harvested 14 h following addition of inhibitors and/or serum deprivation, stained with annexin-5PE (BD) antibody and 7AAD (BD) and flow-sorted using FACS Caliber and De Novo FCS Express V3 software.
###end p 51
###begin title 52
Western blot and immunofluorescence
###end title 52
###begin p 53
###xml 58 59 58 59 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 82 83 82 83 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 325 327 325 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C39">39</xref>
###xml 573 576 573 576 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
###xml 800 802 800 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP195C52">52</xref>
###xml 983 989 <span type="species:ncbi:9793">Donkey</span>
###xml 995 1000 <span type="species:ncbi:10090">Mouse</span>
For western blots, cells were lysed with RIPA buffer (50 mm Tris-HCl pH 8.0, 150 mm NaCl, 0.1% SDS, 1.0% NP-40, 0.5% sodium deoxycholate) containing COMPLETE Protease Inhibitor cocktail (Roche). Equal amounts of protein were run on 4-12% Novex Bis-Tris gels in MOPs buffer. Western blotting was done as previously described (39) using the following antibodies: c-Myc (N-262), BEK (C-17), p16 (M-156), p21 (sc-1207) ERK1 (K-23) and pERK (E-4) from Santa Cruz, p53BP1 (S25) from Bethyl Labs, p53, p53-pS15, pChk2 (Thr68), Akt and pAkt from Cell Signaling Technologies and p19ARF, Chk2, Histone H3, phospho-Histone H3 (ser10) and 53BP1 from Abcam and Trimethyl Histone H3 K9 from Millipore. For immunoflourescence, cells were fixed on coverslips and antibody staining performed as previously described (52). Antibodies used for immunofluorescence included gammaHistone H2AX (pSer139) (Cell Signaling Technologies) pATM (Ser1981) (Upstate) and p53BP1 (S25) (Bethyl Labs). Cy3-conjugated Donkey Anti-Mouse (Jackson Immuno Research) secondary antibody was used. DAPI staining was used to visualize nuclei.
###end p 53
###begin title 54
SUPPLEMENTARY MATERIAL
###end title 54
###begin p 55

###end p 55
###begin title 56
[Supplementary Data]
###end title 56
###begin title 57
FUNDING
###end title 57
###begin p 58
###xml 49 80 49 80 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Shriners Hospitals for Children</funding-source>
###xml 89 118 89 118 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">National Institutes of Health</funding-source>
###xml 72 80 <span type="species:ncbi:9606">Children</span>
###xml 197 205 <span type="species:ncbi:9606">Children</span>
This work was supported by grants to P.J.H. from Shriners Hospitals for Children and the National Institutes of Health. Funding to pay the Open Access charge was provided by Shriners Hospitals for Children.
###end p 58
###begin title 59
ACKNOWLEDGEMENTS
###end title 59
###begin p 60
###xml 94 97 94 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
We thank William Horton and Claudio Basilico for FGFR2 expression constructs and Hu Lu for p53-/- MEFs.
###end p 60
###begin p 61
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of Interest statement</italic>
Conflict of Interest statement. None declared.
###end p 61
###begin title 62
REFERENCES
###end title 62
###begin article-title 63
Mechanisms underlying differential responses to FGF signaling
###end article-title 63
###begin article-title 64
###xml 51 56 <span type="species:ncbi:9606">human</span>
Roles of FGF signaling in skeletal development and human genetic diseases
###end article-title 64
###begin article-title 65
###xml 73 78 <span type="species:ncbi:9606">human</span>
Bad bones, absent smell, selfish testes: the pleiotropic consequences of human FGF receptor mutations
###end article-title 65
###begin article-title 66
###xml 111 116 <span type="species:ncbi:9606">human</span>
Mutations in fibroblast growth factor receptor 2 and fibroblast growth factor receptor 3 genes associated with human gastric and colorectal cancers
###end article-title 66
###begin article-title 67
Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes
###end article-title 67
###begin article-title 68
Inhibition of activated fibroblast growth factor receptor 2 in endometrial cancer cells induces cell death despite PTEN abrogation
###end article-title 68
###begin article-title 69
Drug-sensitive FGFR2 mutations in endometrial carcinoma
###end article-title 69
###begin article-title 70
###xml 42 47 <span type="species:ncbi:9606">human</span>
Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas
###end article-title 70
###begin article-title 71
Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3
###end article-title 71
###begin article-title 72
A novel chromosomal translocation t(4; 14)(p16.3; q32) in multiple myeloma involves the fibroblast growth-factor receptor 3 gene
###end article-title 72
###begin article-title 73
Sequence survey of receptor tyrosine kinases reveals mutations in glioblastomas
###end article-title 73
###begin article-title 74
###xml 101 105 <span type="species:ncbi:10090">mice</span>
###xml 110 116 <span type="species:ncbi:9606">humans</span>
Activating mutations of the tyrosine kinase receptor FGFR3 are associated with benign skin tumors in mice and humans
###end article-title 74
###begin article-title 75
High frequency of FGFR3 mutations in adenoid seborrheic keratoses
###end article-title 75
###begin article-title 76
Fibroblast growth factor receptor 3 mutations in epidermal nevi and associated low grade bladder tumors
###end article-title 76
###begin article-title 77
Genome-wide association study identifies novel breast cancer susceptibility loci
###end article-title 77
###begin article-title 78
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer
###end article-title 78
###begin article-title 79
Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer
###end article-title 79
###begin article-title 80
Cancer genomics and genetics of FGFR2
###end article-title 80
###begin article-title 81
Activation of FGF receptors by mutations in the transmembrane domain
###end article-title 81
###begin article-title 82
Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma
###end article-title 82
###begin article-title 83
The myeloma-associated oncogene fibroblast growth factor receptor 3 is transforming in hematopoietic cells
###end article-title 83
###begin article-title 84
Oncogenic properties of the mutated forms of fibroblast growth factor receptor 3b
###end article-title 84
###begin article-title 85
Cell responses to FGFR3 signalling: growth, differentiation and apoptosis
###end article-title 85
###begin article-title 86
###xml 95 100 <span type="species:ncbi:10090">mouse</span>
RNA interference and inhibition of MEK-ERK signaling prevent abnormal skeletal phenotypes in a mouse model of craniosynostosis
###end article-title 86
###begin article-title 87
Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand
###end article-title 87
###begin article-title 88
Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome
###end article-title 88
###begin article-title 89
Biochemical analysis of pathogenic ligand-dependent FGFR2 mutations suggests distinct pathophysiological mechanisms for craniofacial and limb abnormalities
###end article-title 89
###begin article-title 90
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
###end article-title 90
###begin article-title 91
Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling
###end article-title 91
###begin article-title 92
###xml 14 19 <span type="species:ncbi:9606">human</span>
Senescence of human fibroblasts induced by oncogenic Raf
###end article-title 92
###begin article-title 93
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
###end article-title 93
###begin article-title 94
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
###end article-title 94
###begin article-title 95
The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence
###end article-title 95
###begin article-title 96
Intrinsic tumour suppression
###end article-title 96
###begin article-title 97
DNA damage signalling guards against activated oncogenes and tumour progression
###end article-title 97
###begin article-title 98
Many roads lead to oncogene-induced senescence
###end article-title 98
###begin article-title 99
The p53 pathway: positive and negative feedback loops
###end article-title 99
###begin article-title 100
c-MYC regulates mammalian body size by controlling cell number but not cell size
###end article-title 100
###begin article-title 101
A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation
###end article-title 101
###begin article-title 102
Deletion of Mnt leads to disrupted cell cycle control and tumorigenesis
###end article-title 102
###begin article-title 103
Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
###end article-title 103
###begin article-title 104
c-MYC: more than just a matter of life and death
###end article-title 104
###begin article-title 105
Myc pathways provoking cell suicide and cancer
###end article-title 105
###begin article-title 106
Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain
###end article-title 106
###begin article-title 107
An oncogene-induced DNA damage model for cancer development
###end article-title 107
###begin article-title 108
Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway
###end article-title 108
###begin article-title 109
A negative feedback signaling network underlies oncogene-induced senescence
###end article-title 109
###begin article-title 110
Mnt- Max to Myc-Max complex switching regulates cell cycle entry
###end article-title 110
###begin article-title 111
Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation
###end article-title 111
###begin article-title 112
C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells
###end article-title 112
###begin article-title 113
FGFR2-amplified gastric cancer cell lines require FGFR2 and Erbb3 signaling for growth and survival
###end article-title 113
###begin article-title 114
A dominant repression domain in Tbx3 mediates transcriptional repression and cell immortalization: relevance to mutations in Tbx3 that cause ulnar-mammary syndrome
###end article-title 114

